pharmaphorum1h
Alnylam joins three-way contest in ATTR cardiomyopathy
Alnylam has the FDA approval it sought for Amvuttra in a form of cardiomyopathy associated with rare disease ATTR amyloidosis ...
STAT12h
Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...
What’s Next For COVID Vaccines In NZ? – Expert Q&A
“The latest COVID-19 booster available in New Zealand is the Pfizer-BioNTech’s Comirnaty mRNA vaccine. This targets the Omicron JN.1 variant which is the most common strain currently circulating. This ...
STAT14h
Former FDA commissioner Scott Gottlieb questions RFK Jr.’s measles response, infant formula plan
Trump's former FDA commissioner criticized the current administration's approach to measles and infant formula at #STATBreakthrough ...
Dr. Francis Collins Led the NIH. Now, He Fears for the Future of Science
D r. Francis Collins led the U.S. National Institutes of Health (NIH), the world’s largest funder of biomedical research, ...
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...